Related Experiment Video
Updated: Oct 19, 2025
04:50
Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
426
Inflammatory rheumatic diseases and pregnancy.
Katarzyna Klimaszyk1, Ewa Wender-Ozegowska2, Malgorzata Kedzia2
1Department of Reproduction, Poznań University of Medical Sciences, Poznan, Poland. kedjaworska@gmail.com.
Ginekologia Polska
|September 20, 2021
Summary
Planning pregnancy is crucial for women with systemic connective tissue disorders. Close collaboration between specialists ensures better outcomes and manages risks for a healthy pregnancy.
Area of Science:
- Rheumatology
- Obstetrics & Gynecology
- Maternal-Fetal Medicine
Background:
- Systemic connective tissue disorders (SCTD) present unique challenges during pregnancy.
- Managing these conditions requires multidisciplinary collaboration for optimal maternal and fetal health.
- Pregnancy outcomes in SCTD patients are influenced by disease activity and management strategies.
Purpose of the Study:
- To review current knowledge on managing pregnant patients with SCTD.
- To emphasize the importance of proactive pregnancy planning in this high-risk group.
- To highlight the necessity of specialized gynecological supervision during pregnancy.
Main Methods:
- Literature review of studies on pregnancy in patients with systemic connective tissue diseases.
- Synthesis of current guidelines and expert recommendations.
- Analysis of factors influencing pregnancy outcomes in this population.
Main Results:
- Effective management of the underlying connective tissue disorder before conception is key.
- Careful timing of pregnancy significantly impacts success rates.
- Enhanced gynecological monitoring is essential to mitigate increased complication risks.
Conclusions:
- Pregnancy in women with SCTD necessitates a collaborative approach between rheumatologists and gynecologists.
- Optimizing disease control and planning conception are critical for favorable pregnancy results.
- Tailored obstetric surveillance is vital for managing the heightened risk of complications.
Related Concept Videos
01:23Rheumatic Heart Disease I: Introduction
102
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
102
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
122
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
122
01:21Rheumatic Heart Disease III: Medical Management
62
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
62
01:20Rheumatic Heart Disease IV: Nursing Management
67
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
67
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
259
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
259
01:30Inflammatory Bowel Disease II: Crohn's Disease
467
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
467